Ledger.Open graph →
SEC Form D · Amendment · filed May 10, 2017

Batu Biologics, Inc

Offering
$1.2M
Sold
$508K
Exemption
Rule 506(c)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (22)

Gerry N. Berg · San Diego, CAExecHong N. Ma · San Diego, CADirectorSamuel C. Wagner · San Diego, CADirectorThomas E. Ichim · San Diego, CADirectorVladimir N. Bogin · San Diego, CADirectorAlan N. Lewis · San Diego, CADirectorDimitrios N. Theofilopoulos · San Diego, CAExecDaniel E. Raynor · New York, NYDirectorTimothy M. Weaver · Waltham, MADirectorJohn M. Deane · Waltham, MAExecRaymond T. Dalio · WESTPORT, CTDirectorJohn N. Peck · Rancho Santa Fe, CADirectorJohn N. Chiplin · San Diego, CADirectorGayl A. Mileszko · Boston, MAExec · DirectorArthur J. Wunder · Boston, MAExec · DirectorLyn Zahnow · Atlanta, GADirectorRuth Fowler · Atlanta, GADirectorTodd W. Mansfield · Charlotte, NCDirectorJulius Knowles · Cambridge, MAExecRoger Kitterman · Cambridge, MADirectorJohn N. Peck · Rancho Santa Fe, CADirectorJohn N. Chiplin · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗